Christine Clavel

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjosé, Wim Quint, Laia Alemany et al. · The Lancet Oncology · 2010 · 2.7K citations

Invasive Cervical Cancer, Epidemiology, Cervical Cancer Screening +11

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

Joakim Dillner, Matejka Rebolj, Philippe Birembaut et al. · BMJ · 2008 · 627 citations · Full text

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

Nubia Muñóz, Ricardo Manalastas, Punee Pitisuttithum et al. · The Lancet · 2009 · 477 citations

Gynecology, Cervical Cancer Prevention, Human Papillomavirus Vaccines +16

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

Christine Clavel, Marie Masure, J Bory et al. · British Journal of Cancer · 2001 · 474 citations · Full text

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

Laia Alemany, Maëlle Saunier, Isabel Alvarado‐Cabrero et al. · International Journal of Cancer · 2014 · 360 citations · Full text

Precancerous Lesions, Type Distribution, Pathology +17